These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2081256)

  • 1. Replacement estrogen use and body mass index.
    García Rodríguez LA; Pfaff GM; Schumacher MC; Walker AM; Hoffmeister H
    Epidemiology; 1990 May; 1(3):219-23. PubMed ID: 2081256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk: effects of estrogen replacement therapy and body mass.
    Harris RE; Namboodiri KK; Wynder EL
    J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study.
    Kaufman DW; Palmer JR; de Mouzon J; Rosenberg L; Stolley PD; Warshauer ME; Zauber AG; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1375-85; discussion 1396-401. PubMed ID: 1663700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
    Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
    Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
    Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement estrogens and breast cancer.
    Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
    Am J Epidemiol; 1980 Nov; 112(5):586-94. PubMed ID: 7435487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study.
    Cantwell MM; Lacey JV; Schairer C; Schatzkin A; Michaud DS
    Int J Cancer; 2006 Nov; 119(10):2398-401. PubMed ID: 16894568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass.
    Aloia JF; Vaswani A; Russo L; Sheehan M; Flaster E
    Am J Obstet Gynecol; 1995 Mar; 172(3):896-900. PubMed ID: 7892882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are women using postmenopausal estrogens? A community survey.
    Harris RB; Laws A; Reddy VM; King A; Haskell WL
    Am J Public Health; 1990 Oct; 80(10):1266-8. PubMed ID: 2400044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal smoking, estrogen replacement therapy, and the risk of endometrial cancer.
    Franks AL; Kendrick JS; Tyler CW
    Am J Obstet Gynecol; 1987 Jan; 156(1):20-3. PubMed ID: 3799753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of breast cancer.
    Marchant DJ
    Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
    Colditz GA
    J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.